Pharmacology

You are here

Educating the Public about Removal of Essential -Use Designation for Epinephrine

Dr. Reidenberg is one of three outside speakers invited by the FDA to speak at an FDA public workshop on Sept. 25, 2009. The workshop, "Educating the Public about Removal of Essential -Use Designation for Epinephrine" is to address anticipated consequences of the removal of the non-prescription asthma inhaler of epinephrine with no replacement by a non-prescription medication.

Weill Cornell Medicine Pharmacology 1300 York Avenue,
Room E-409
New York, NY 10021 Phone: (212) 746-6250 Fax: (212) 746-8835